We are live on !
Find out more
TS
Third Security Portfolio holdings
AUM
$241M
Turnover
0%
1-Year Est. Return
45.43%
This Fund
S&P 500
This Quarter Est. Return
-34.11%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$2.51B
AUM Growth
-$1.31B
(-34%)
Cap. Flow
+$16M
Cap. Flow % of AUM
Cap. Flow %
0.63%
Top 10 Holdings %
Top 10 Hldgs %
98.94%
Holding
18
New
1
Increased
3
Reduced
–
Closed
–
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Armata Pharmaceuticals
ARMP
|
+$7.57M |
| 2 |
FCSC
Fibrocell Science Inc.
FCSC
|
+$5.76M |
| 3 |
Theriva Biologics
TOVX
|
+$2.63M |
| 4 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$48 |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 97.29% |
| 2 | Energy | 2.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Precigen
PGEN
$2.37B
| $1.96B | 78.09% |
62,280,204
| – | – |
2013 Q3
8 quarters
|
|
2
Halozyme
HALO
$14B
| $266M | 10.59% |
19,829,337
| – | – |
2013 Q2
9 quarters
|
|
3
Alaunos Therapeutics
TCRT
$7.82M
| $87.1M | 3.46% |
64,438
| – | – |
2013 Q2
9 quarters
|
|
|
FCSC
4
DELISTED
Fibrocell Science Inc.
FCSC
| $64M | 2.55% |
1,108,028
+65,066
| +6% | +$5.76M |
2013 Q2
9 quarters
|
|
|
5
Theriva Biologics
TOVX
$9.5M
| $30.1M | 1.2% |
1,513
+107
| +8% | +$2.63M |
2013 Q2
9 quarters
|
|
6
Enterprise Products Partners
EPD
$79.4B
| $25.8M | 1.03% |
1,035,834
| – | – |
2013 Q2
9 quarters
|
|
7
Oragenics
OGEN
$1.94M
| $16.1M | 0.64% |
547
| – | – |
2013 Q2
9 quarters
|
|
8
Energy Transfer Partners
ET
$69.6B
| $15.7M | 0.62% |
752,400
| – | – |
2013 Q2
9 quarters
|
|
9
Ocugen
OCGN
$274M
| $10.7M | 0.43% |
44,843
| – | – |
2014 Q4
3 quarters
|
|
10
Genesis Energy
GEL
$1.7B
| $8.32M | 0.33% |
217,000
| – | – |
2013 Q2
9 quarters
|
|
11
DELISTED
NuStar Energy L.P.
NS
| $5.22M | 0.21% |
116,500
| – | – |
2013 Q2
9 quarters
|
|
|
TCP
12
DELISTED
TC Pipelines LP
TCP
| $4.62M | 0.18% |
97,000
| – | – |
2013 Q2
9 quarters
|
|
|
13
Armata Pharmaceuticals
ARMP
$122M
| $4.58M | 0.18% |
+8,277
| New | +$7.57M |
2015 Q3
0 quarters
|
|
14
Martin Midstream Partners
MMLP
$77.9M
| $3.46M | 0.14% |
141,800
| – | – |
2013 Q2
9 quarters
|
|
|
ETP
15
DELISTED
Energy Transfer Partners L.p.
ETP
| $3.19M | 0.13% |
77,635
+1
| +0% | +$48 |
2015 Q2
1 quarter
|
|
16
Tempest Therapeutics
TPST
$10.4M
| $3.17M | 0.13% |
128
| – | – |
2013 Q4
7 quarters
|
|
|
CMLP
17
DELISTED
CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE)
CMLP
| $1.76M | 0.07% |
284,620
| – | – |
2013 Q4
7 quarters
|
|
18
Precipio
PRPO
$39.5M
| $709K | 0.03% |
86
| – | – |
2014 Q2
5 quarters
|
|
Similar funds
KRC
A
AIA
FG
RFA
UIA
GCM
GMA
Third Security's Q3 2015 Portfolio in Review
As of Q3 2015, Third Security held 18 positions worth $2.51B, down 34% from $3.83B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Third Security's Q3 2015 filing shows 1 new and 3 increased positions. Its largest new stake was Armata Pharmaceuticals: 8,277 shares worth $4.58M.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 98% a quarter earlier, followed by Energy.
- Third Security's largest Q3 2015 buy was Armata Pharmaceuticals: 8,277 shares worth $4.58M.
- Third Security added most to Fibrocell Science Inc. in Q3 2015, an estimated $5.76M increase.
- Third Security's ten largest holdings make up 99% of its $2.51B portfolio in Q3 2015.
- Third Security opened 1 new position and closed 0 in Q3 2015.
- Third Security's portfolio value fell 34% quarter-over-quarter to $2.51B.
Based on Third Security's 13F filing for Q3 2015, filed 20 Oct 2015.